Mesoblast Ltd - ADR

Mesoblast Ltd - ADR

MESO

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.24B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mesoblast Ltd - ADRMesoblast Ltd - ADR-23.2--16%-0.2
$-5.02

Current Fair Value

131.2% downside

Overvalued by 131.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.24 Billion
Enterprise Value$2.24 Billion
Dividend Yield$- (-)
Earnings per Share$-0.84
Beta0.8
Outstanding Shares129,138,263

Return

Return on Equity-16.42%ROE
Return on Assets-12.06%
Return on Invested Capital-10.82%

Valuation & Multiples

P/E Ratio-23.16P/E Ratio
PEG142.81PEG
Price to Sales-Price to Sales
Price to Book Ratio4.02Price to Book Ratio
Enterprise Value to Revenue34.33
Enterprise Value to EBIT-31.72
Enterprise Value to Net Income-24
Total Debt to Enterprise0.06
Debt to Equity0.24Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
February 26, 2026
EPS Estimate
$-0.24
Average shareholder expectation
Revenue Estimate
$53.06 M
Average shareholder expectation

Next Earnings Call

Expected Date
September 2, 2026
EPS Estimate
$-0.06
Average shareholder expectation
Revenue Estimate
$72.44 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.1126 3.91%
Total Calls1,384,100 31.12%
Total Puts155,900 5.55%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.55% 0.74%
Total Invested$50.54M 32.93%
Investors Holding75 7.00%

ESG Score

No data

About Mesoblast Ltd

CEO: Silviu Itescu